Eun Jung Jang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eun Jung Jang has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Young-Joon Park
Division of Tuberculosis Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea
8 shared publications - Ryu Kyung Kim
Korea Disease Control and Prevention Agency, Cheongju, Korea
7 shared publications - Sangwon Lee
Department of Disease Data Science, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
7 shared publications - Young June Choe
Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea
6 shared publications - Ji Hae Hwang
Division of Epidemiological Investigation Analysis, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
3 shared publications - Jia Kim
Korea Disease Control and Prevention Agency, Cheongju, Korea
3 shared publications
Latest Publications
- Open Access
- 1 January 2024
- Published by XMLink in Pediatric Infection & Vaccine
- Vol. 31 (1) , 113-121
COVID-19 Rapid Antigen Test Results in Preschool and School (March 2 to May 1, 2022)
윤고운, et al. Pediatr Infect Vaccine. 2024 Apr;31(1):113-121. https://doi.org/10.14776/piv.2024.31.e5
- 1 January 2024
- Published by XMLink in Pediatric Infection & Vaccine
- Vol. 31 (1) , 113-121
Open AccessCOVID-19 Rapid Antigen Test Results in Preschool and School (March 2 to May 1, 2022)
윤고운, et al. Pediatr Infect Vaccine. 2024 Apr;31(1):113-121. https://doi.org/10.14776/piv.2024.31.e5
- Open Access
- 30 June 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (3) , 164-172
Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea
Objectives: The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea’s nationwide vaccination campaign.Methods: We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.Results: There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901–120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909–138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659–96,913) severe cases and 112,195 (95% CI, 110,870–113,520) deaths were prevented as a result of the vaccination campaign.Conclusion: We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea’s nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.
- 30 June 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (3) , 164-172
Open AccessEstimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea
Objectives: The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea’s nationwide vaccination campaign.Methods: We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.Results: There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901–120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909–138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659–96,913) severe cases and 112,195 (95% CI, 110,870–113,520) deaths were prevented as a result of the vaccination campaign.Conclusion: We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea’s nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (46) , e396
Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
Kim RK, et al. J Korean Med Sci. 2023 Nov;38:e396. https://doi.org/10.3346/jkms.2023.38.e396
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (46) , e396
Open AccessComparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
Kim RK, et al. J Korean Med Sci. 2023 Nov;38:e396. https://doi.org/10.3346/jkms.2023.38.e396
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (34) , e269
Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (34) , e269
Open AccessRisk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (19) , e143
Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
Park SK, et al. J Korean Med Sci. 2023 Apr;38(19):e143. https://doi.org/10.3346/jkms.2023.38.e143
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (19) , e143
Open AccessEffectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
Park SK, et al. J Korean Med Sci. 2023 Apr;38(19):e143. https://doi.org/10.3346/jkms.2023.38.e143
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (11) , e87
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
Kim YY, et al. J Korean Med Sci. 2023 Mar;38(11):e87. https://doi.org/10.3346/jkms.2023.38.e87
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (11) , e87
Open AccessVaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
Kim YY, et al. J Korean Med Sci. 2023 Mar;38(11):e87. https://doi.org/10.3346/jkms.2023.38.e87
- Open Access
- 14 October 2022
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 13 (5) , 377-381
Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
Objectives: We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as of April 2022 using the national registry. Methods: We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.Results: Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and vaccination, and 9.9% had no immunity,. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80% to 85%; however, nearly half of the children were presumed to have no immunity.Conclusion: We report a gap in population immunity, with lower presumed protection in children than in adults. The approach presented in this work can provide valuable informed tools to assist vaccine policy-making at a national level.
- 14 October 2022
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 13 (5) , 377-381
Open AccessPresumed population immunity to SARS-CoV-2 in South Korea, April 2022
Objectives: We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as of April 2022 using the national registry. Methods: We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.Results: Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and vaccination, and 9.9% had no immunity,. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80% to 85%; however, nearly half of the children were presumed to have no immunity.Conclusion: We report a gap in population immunity, with lower presumed protection in children than in adults. The approach presented in this work can provide valuable informed tools to assist vaccine policy-making at a national level.
- Open Access
- 2 August 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (11) , 5589-5592
Reinfection with SARS‐CoV‐2 in general population, South Korea; nationwide retrospective cohort study
To better understand the epidemiology of SARS‐CoV‐2 reinfections, we analyzed national data from South Korean who were followed longitudinally from January 2020 to April 2022. We conducted a nationwide retrospective cohort study to estimate possible SARS‐CoV‐2 reinfection rates in all residents in South Korea, with at least two episodes of laboratory‐confirmed SARS‐CoV‐2 infection by reverse‐transcriptase polymerase chain reaction or rapid antigen test (RAT) performed at least 45 or more days between both episodes, between January 2020 and April 2022. There were 16 130 855 laboratory‐confirmed SARS‐CoV‐2 cases in South Korea, with 55 841 (346.2 per 100 000; or 0.3% of all infections) cases of possible reinfections. The reinfection rate has increased from 6.0 cases per 100 000 during Pre‐Delta period to 128.0 cases per 100 000 and 355.1 cases per 100 000 during Delta and Omicron periods, respectively. Persons with one dose of vaccination had the highest reinfection rate of 642.2 per 100 000, followed by unvaccinated persons (536.2/100 000) and two‐dose vaccinated persons (406.3/100 000). Our finding suggests that the majority of possible reinfections occurred following the emergence of new variants.
- 2 August 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (11) , 5589-5592
Open AccessReinfection with SARS‐CoV‐2 in general population, South Korea; nationwide retrospective cohort study
To better understand the epidemiology of SARS‐CoV‐2 reinfections, we analyzed national data from South Korean who were followed longitudinally from January 2020 to April 2022. We conducted a nationwide retrospective cohort study to estimate possible SARS‐CoV‐2 reinfection rates in all residents in South Korea, with at least two episodes of laboratory‐confirmed SARS‐CoV‐2 infection by reverse‐transcriptase polymerase chain reaction or rapid antigen test (RAT) performed at least 45 or more days between both episodes, between January 2020 and April 2022. There were 16 130 855 laboratory‐confirmed SARS‐CoV‐2 cases in South Korea, with 55 841 (346.2 per 100 000; or 0.3% of all infections) cases of possible reinfections. The reinfection rate has increased from 6.0 cases per 100 000 during Pre‐Delta period to 128.0 cases per 100 000 and 355.1 cases per 100 000 during Delta and Omicron periods, respectively. Persons with one dose of vaccination had the highest reinfection rate of 642.2 per 100 000, followed by unvaccinated persons (536.2/100 000) and two‐dose vaccinated persons (406.3/100 000). Our finding suggests that the majority of possible reinfections occurred following the emergence of new variants.
- 30 June 2021
- Published by Korean Open Association for Early Childhood Education in The Journal of Korea Open Association for Early Childhood Education
- Vol. 26 (3) , 115-143
Case-based learning(CBL) model design and its application in early childhood education to enhance teachers’ responsive interactions
본 연구의 목적은 교사의 반응성 상호작용을 증진할 수 있는 사례기반학습을 설계하고 유아교사를 대상으로 교육을 실시하여 그 효과를 검증하는 것이다. 연구 목적을 달성하기 위해 문헌분석, 사례수집 및 범주화, 교사 심층면담, 전문가 검토 등을 통해 사례기반학습을 설계하고, 유아교사를 대상으로 사례기반학습을 적용한 교육을 실시하였다. 또한, 유아교사의 반응성 상호작용을 관찰하고, 대비분석을 통해 사례기반 학습의 효과를 검증하였다. 연구결과, 첫째, 사례기반학습은 교수학습 단계 선정, 교수학습 전략 선정, 놀이 사례 시나리오 선정, 사례분석 준거 도출, 예비 연구, 최종설계안 도출의 6단계 과정을 거쳐 설계되었다. 둘째, 사례기반학습은 유아교사의 반응성 상호작용에 긍정적인 영향을 주는 것으로 나타났다. 본 연구는 유아교사의 실천적 지식 향상을 위한 지원 방안으로 사례기반학습의 현장 적용 가능성을 제고하고, 유아 중심의 교실을 만드는데 필요한 전략 수립을 위한 기초자료를 제공할 수 있을 것이다.
- 30 June 2021
- Published by Korean Open Association for Early Childhood Education in The Journal of Korea Open Association for Early Childhood Education
- Vol. 26 (3) , 115-143
Case-based learning(CBL) model design and its application in early childhood education to enhance teachers’ responsive interactions
본 연구의 목적은 교사의 반응성 상호작용을 증진할 수 있는 사례기반학습을 설계하고 유아교사를 대상으로 교육을 실시하여 그 효과를 검증하는 것이다. 연구 목적을 달성하기 위해 문헌분석, 사례수집 및 범주화, 교사 심층면담, 전문가 검토 등을 통해 사례기반학습을 설계하고, 유아교사를 대상으로 사례기반학습을 적용한 교육을 실시하였다. 또한, 유아교사의 반응성 상호작용을 관찰하고, 대비분석을 통해 사례기반 학습의 효과를 검증하였다. 연구결과, 첫째, 사례기반학습은 교수학습 단계 선정, 교수학습 전략 선정, 놀이 사례 시나리오 선정, 사례분석 준거 도출, 예비 연구, 최종설계안 도출의 6단계 과정을 거쳐 설계되었다. 둘째, 사례기반학습은 유아교사의 반응성 상호작용에 긍정적인 영향을 주는 것으로 나타났다. 본 연구는 유아교사의 실천적 지식 향상을 위한 지원 방안으로 사례기반학습의 현장 적용 가능성을 제고하고, 유아 중심의 교실을 만드는데 필요한 전략 수립을 위한 기초자료를 제공할 수 있을 것이다.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (50) , e346
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
Lee JJ, et al. J Korean Med Sci. 2021 Dec;36(50):e346. https://doi.org/10.3346/jkms.2021.36.e346
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (50) , e346
Open AccessImportation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
Lee JJ, et al. J Korean Med Sci. 2021 Dec;36(50):e346. https://doi.org/10.3346/jkms.2021.36.e346